Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein and chloride channel that regulates the movement of chloride and bicarbonate ions across epithelial cell membranes. Mutations in the *CFTR* gene cause cystic fibrosis, a genetic disorder characterized by thickened secretions in the lungs, pancreas, and other organs.
CFTR potentiators enhance the channel-opening probability (gating) of mutant CFTR proteins at the cell surface. CFTR correctors promote the proper folding and trafficking of misfolded CFTR proteins to the cell surface.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel (CFTR).